chr1-152351004-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001014342.3(FLG2):c.6782G>A(p.Ser2261Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,613,540 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001014342.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLG2 | NM_001014342.3 | c.6782G>A | p.Ser2261Asn | missense_variant | 3/3 | ENST00000388718.5 | NP_001014364.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLG2 | ENST00000388718.5 | c.6782G>A | p.Ser2261Asn | missense_variant | 3/3 | 5 | NM_001014342.3 | ENSP00000373370.4 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151704Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251382Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135856
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461836Hom.: 0 Cov.: 36 AF XY: 0.0000151 AC XY: 11AN XY: 727228
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151704Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74072
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2024 | The c.6782G>A (p.S2261N) alteration is located in exon 3 (coding exon 2) of the FLG2 gene. This alteration results from a G to A substitution at nucleotide position 6782, causing the serine (S) at amino acid position 2261 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at